Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06075134
Other study ID # SFAkhnokh
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 2023
Est. completion date August 2024

Study information

Verified date October 2023
Source Cairo University
Contact Sherry Fayez Akhnokh, BSc
Phone +0201284857175
Email sherry.akhnokh@dentistry.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effect of EMG-guided Botox injection with conventional Botox injection in Yonsei point, in patients with excessive gingival display. The main question it aims to answer is: • Does the use of electromyography (EMG) as a guide during Botox injection for patients with gummy smile has better effect than conventional injection in Yonsei point? Participants will be randomized in equal proportions between intervention and control groups. - Preoperative assessment of amount of gingival display, lip length (philtrum and vermilion length), and smile type. - For the intervention group, EMG readings will be done in Clinical Neurophysiology Department, Kasr Al-Ainy Hospital EMG-guided Botox injection (Intervention group). Conventional Botox injection in Yonsei point (Control group).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 32
Est. completion date August 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Patients with excessive gingival display. - Patients with esthetic concerns. - Patients with mild to moderate VME (vertical maxillary excess). - Normal clinical crown dimensions. - Patients aged 18 to 50. - Systemically healthy patients. - Non-smokers. Exclusion Criteria: - Patients with severe VME (vertical maxillary excess). - Pregnant and breastfeeding women. - Patients with gingival inflammation and/or enlargement. - Inflammation or infection at the site of injection. - Patients with known allergy to any of the components of Botox (i.e., saline, human albumin, lactose and sodium succinate). - Patients using anticholinesterase or other agents affecting neuromuscular transmission. - Psychologically unstable patients or those who have unrealistic expectations and questionable motives. - Patients with neuromuscular disorders (e.g., myasthenia gravis, Eaton-Lambert syndrome).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Botox injection
Botox injection
Device:
EMG
Quantitative Electromyography
Drug:
Zinc Supplement
To increase efficacy of Botox

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in amount of gingival display Will be measured using ruler in mm. Baseline, One-week, One-month, three-months, and six-months follow-up
Secondary Quantitative EMG Will be measured using EMG in mv. Baseline, One-week and six-months follow-up
Secondary Patient satisfaction Will be assessed using questionnaire, on a scale from 1 to 5, where 1 is completely not satisfied and 5 is completely satisfied. Baseline, One-week, One-month, three-months, and six-months follow-up
Secondary Post-operative pain Will be measured using visual analogue scale (VAS) from 1 to 10. Baseline, One-week, and One-month follow-up
Secondary Smile type Qualitative, by Rubin (1974). Smile is classified into 1. Corner of the mouth (Mona Lisa) smile, 2. Canine Smile, and 3. Full denture smile Baseline, One-week, One-month, three-months, and six-months follow-up
Secondary Change in lip length Will be measured using UNC (University of North Carolina) -15 periodontal probe in mm. Baseline, One-week, One-month, three-months, and six-months follow-up
Secondary Esthetics (Symmetry) for operators Will be measured using 5-point Likert scale, where 1 is significantly asymmetrical and 5 is completely symmetrical. Baseline, One-week, One-month, three-months, and six-months follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06017791 - Management of Excess Gingival Display Using Tunnel Technique With 3D Designed PEEK Shell: A Case Series N/A
Completed NCT03717987 - The Effect of Botulinum Toxin A In Patients With Excessive Gingival Display With And Without Zinc Supplementation Phase 3
Not yet recruiting NCT06148961 - Effect of Botox Before Modified Lip Repositioning Repositioning Only in Relapse of the Excessive Gingival Display Within One Year N/A